| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4302054 | Journal of Surgical Research | 2011 | 8 Pages |
Abstract
Thus, ETS-GS lowered ROS levels in cultured cells, reduced serum NO levels, decreased renal MDA levels, and protected rats against I/R-induced kidney injury. Given these in vitro and in vivo findings, ETS-GS is a strong candidate for future exploration of therapeutic potential in various human I/R diseases.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Satoshi M.D., Ph.D., Hironori M.D., Hideo M.D., Ph.D., Kyosuke M.D., Akira Hasegawa, Jyunya M.D., Isao M.D., Ph.D., Takayuki M.D., Ph.D.,